Perfil
Matthew Parris formerly worked at Aegerion Pharmaceuticals, Inc., as Director-Clinical Operations, Inovio Pharmaceuticals, Inc., as Director-Clinical Operations, and Eleison Pharmaceuticals, Inc., as Vice President-Clinical Development.
Mr. Parris received his undergraduate degree from Imperial College London.
Antiguos cargos conocidos de Matthew Parris.
| Empresas | Cargo | Fin |
|---|---|---|
| AEGERION PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
| INOVIO PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Eleison Pharmaceuticals, Inc.
Eleison Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes clinical stage drug candidates for orphan cancers | Corporate Officer/Principal | - |
| TRAWS PHARMA, INC. | Director Técnico/Científico/I+D | - |
Formación de Matthew Parris.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 5 |
|---|---|
Traws Pharma, Inc.
Traws Pharma, Inc. BiotechnologyHealth Technology Discovers and develops products for patients with cancer | Health Technology |
Aegerion Pharmaceuticals, Inc.
Aegerion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes therapies for hyperlipidemia and metabolic diseases | Health Technology |
Imperial College London
Imperial College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Inovio Pharmaceuticals, Inc.
Inovio Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops synthetic vaccines and immune therapies for cancers and infectious diseases | Health Technology |
Eleison Pharmaceuticals, Inc.
Eleison Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes clinical stage drug candidates for orphan cancers | Health Technology |
- Bolsa de valores
- Insiders
- Matthew Parris
















